BCL3 anticorps
Aperçu rapide pour BCL3 anticorps (ABIN7255680)
Antigène
Voir toutes BCL3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Attributs du produit
- Polyclonal Antibody
-
Purification
- Affinity purification
-
Immunogène
- A synthetic peptide of human BCL3 (NP_005169.2).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB 1:500-1:2000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- BCL3 (B-Cell CLL/lymphoma 3 (BCL3))
-
Autre désignation
- BCL3
-
Sujet
- This gene is a proto-oncogene candidate. It is identified by its translocation into the immunoglobulin alpha-locus in some cases of B-cell leukemia. The protein encoded by this gene contains seven ankyrin repeats, which are most closely related to those found in I kappa B proteins. This protein functions as a transcriptional co-activator that activates through its association with NF-kappa B homodimers. The expression of this gene can be induced by NF-kappa B, which forms a part of the autoregulatory loop that controls the nuclear residence of p50 NF-kappa B.
-
Poids moléculaire
-
Observed_MW: 47 kDa
Calculated_MW: 47 kDa
-
ID gène
- 602
-
UniProt
- P20749
-
Pathways
- Signalisation NF-kappaB, Maintenance of Protein Location, Protein targeting to Nucleus
Antigène
-